Revenio Group

Bewertungs-Analyse

Über das Unternehmen

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Probes that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or emergency settings; and iCare TONOVET Plus tonometer, which is used for measuring IOP on animal patients by general veterinary practitioners, veterinary ophthalmologists and other veterinary medical personnel. It also provides imaging devices comprising iCare EIDON, a device with confocal retinal imaging; iCare DRSplus, a d

Trading-Daten

💵 Dividenden-Info

Ähnliche Aktien aus dem Sektor

Wo kann ich Revenio Group kaufen?

Vergleiche die besten Broker — niedrige Gebühren, seriöse Anbieter, reguliert.